Issue 1-2/2003
Content (12 Articles)
Brain sites of movement disorder: Genetic and environmental agents in neurodevelopmental perturbations
T. Palomo, R. J. Beninger, R. M. Kostrzewa, T. Archer
Neuromelanin and its interaction with iron as a potential risk factor for dopaminergic neurodegeneration underlying Parkinson's disease
Manfred Gerlach, Kay L. Double, Dorit Ben-Shachar, Luigi Zecca, Moussa B. H. Youdim, Peter Riederer
Neurobehavioural deficits following postnatal iron overload: I spontaneous motor activity
A. Fredriksson, N. Schröder, T. Archer
Neurobehavioural deficits following postnatal iron overload: II instrumental learning performance
T. Archer, N. Schoröder, A. Fredriksson
Effects of acute administration of DA agonists on locomotor activity: MPTP versus neonatal intracerebroventricular 6-OHDA treatment
Trevor Archer, Tomas Palomo, Robert McArthur, Anders Fredriksson
Dopamine receptor supersensitivity: An outcome and index of neurotoxicity
Richard M. Kostrzewa, John P. Kostrzewa, Ryszard Brus
Neurotrophic factors for the investigation and treatment of movement disorders
Justo Garcia De Yébenes, Marina Sánchez, Maria Angeles Mena
Striatal glutamatergic mechanisms and extrapyramidal movement disorders
Thomas N. Chase, Francesco Bibbiani, Justin D. Oh
A possible physiological role for cerebral tetrahydroisoquinolines
Jerzy Vetulani, Lucyna Antkiewicz-Michaluk, Irena Nalepa, Mario Sansone
Axonal degeneration and progressive neurologic disability in multiple sclerosis
Carl Bjartmar, Bruce D. Trapp